Abstract:<h3 class="a-plus-plus">Abstract</h3> <span class="a-plus-plus abstract-section id-a-sec1"> <h3 class="a-plus-plus">Objectives</h3> <p class="a-plus-plus">To determine the feasibility and performance of sentinel lymph-node (SLN) mapping among women with high-risk endometrial cancer (EC).</p> </span> <span class="a-plus-plus abstract-section id-a-sec2"> <h3 class="a-plus-plus">Materials and methods</h3> <p class="a-plus-plus">Ninety-eight patients at high-risk EC were enrolled in this retrospective surgical trial from August 2016 to August 2018. All patients underwent intraoperative SLN biopsy, with ICG injection for laparoscopic staging; this was followed by pelvic and paraaortic lymphadenectomy (LAD). Outcomes included SLN detection rate, false-negative SLN algorithm rate, and the negative predictive value (NPV) of the SLN algorithm. The Chi-square test was used to analyze the relationship between SLN mapping and the risk factors. Then, we performed Kappa consistency check (<em class="a-plus-plus">P</em> < 0.05 with Meaning), to estimate the consistency of SLN and lymph-node metastasis.</p> </span> <span class="a-plus-plus abstract-section id-a-sec3"> <h3 class="a-plus-plus">Results</h3> <p class="a-plus-plus">Successful biopsy occurred in 94 patients (170 sides) among 98 patients (196 sides). At least 1 SLN was identified in 86.7% (170/196). Overall, the false-negative rate (FNR) was 11.8% (2/17), NPV was 97.3% (72/74), and sensitivity was 88.2% (15/17). 22/98 patients (22.4%) with high-risk EC had at least one metastatic lymph node identified. When the SLN algorithm was retrospectively applied, the FNR was 9.1% (2/22) and sensitivity was 90.9% (20/22). Considering the surgeon’s experience, 68 cases of EC (except for 30 patients), the detection rate was 89.7% (122/136), NPV was 98.1% (50/51), and the FNR was 5.6% (1/18). The factor significantly affecting the detection rate of SLNs was lymphovascular space invasion (LVSI) (<em class="a-plus-plus">P</em> = 0.016). SLN metastasis of EC was associated with depth of myometrial invasion (<em class="a-plus-plus">P</em> = 0.034). The analysis result of SLN and the consistency of pelvic lymph-node metastasis status. As detected by Kappa coefficient was 0.939 (<em class="a-plus-plus">P</em> < 0.001), suggests highly consistency.</p> </span> <span class="a-plus-plus abstract-section id-a-sec4"> <h3 class="a-plus-plus">Conclusions</h3> <p class="a-plus-plus">Our SLN detection rate for high-risk EC was the same as previously reported. When SLN is not detected, better after 30 patients’ experience, is a reasonable alternative to complete LAD in high-risk EC. In addition, SLN shows high co-occurrence with pelvic lymph nodes. Therefore, SLN biopsy can be used to diagnose high-risk EC.</p> </span>

Is it safe to operate selected low-risk endometrial cancer patients in secondary hospitals?

Non-exenterative surgical management of recurrent endometrial carcinoma

Stage II endometrial cancer: The diagnostic power of hysteroscopic excisional biopsy and MRI in the pre-operative cervical stroma assessment

Minimally invasive surgery versus open surgery in high-risk histologic endometrial cancer patients: A meta-analysis

Early oncological outcomes and accuracy of risk stratification and tailoring surgical staging based on preoperative histology, Ca125 and MRI in endometrial cancer: a prospective cohort study

Evaluation of the Accuracy of Intra-Operative Gross Examination for the Surgical Management of Endometrial Cancer.

Safety of diagnostic hysteroscopy for the investigation of type II endometrial cancer: systematic review with meta-analysis

Preoperative assessment of lymph node metastasis in endometrial cancer: A Korean Gynecologic Oncology Group study

Should we prioritise proper surgical staging for patients with Atypical endometrial hyperplasia (AEH)? Experience from a single-institution tertiary care oncology centre

Accuracy of robotic sentinel lymph node detection (RSLND) for patients with endometrial cancer (EC)

Preoperative MRI and immunohistochemical examination for the prediction of high-risk endometrial cancer

Overall and progression-free survival in endometrial carcinoma: A single-center retrospective study of patients treated between 2000-2018

Prevalence and size of pelvic sentinel lymph node metastases in endometrial cancer

Preoperative Evaluation Of Serum Ca-125 Levels Maybe A More Significantly Prognostic Factor In Low To Intermediate-Risk Endometrial Carcinoma: A Multi-Institutional Study

Preoperative Assessment for High‐Risk Endometrial Cancer by Developing an MRI‐ and Clinical‐Based Radiomics Nomogram: A Multicenter Study

Precise lymph node biopsy for endometrial cancer confined to the uterus: Analysis of 43 clinical cases

Is Diagnostic Hysteroscopy Safe for the Investigation of Type II Endometrial Cancer? A Retrospective Cohort Analysis

Efficacy and diagnostic reliability of intraoperative frozen section in the surgical management of early-stage cervical cancer

Survival benefit of surgical treatment for patients with stage IVB endometrial cancer: a propensity score-matched SEER database analysis

A retrospective validation study of sentinel lymph node mapping for high-risk endometrial cancer

Evaluation of Different Risk Factors for Metastatic Sentinel Lymph Nodes in Endometrial Cancer